
Axsome Therapeutics Investor Relations Material
Latest events

Q1 2025
Axsome Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Axsome Therapeutics Inc
Access all reports
Axsome Therapeutics Inc. is a biopharmaceutical company focused on developing and commercializing therapies for central nervous system (CNS) disorders. The company's portfolio includes product candidates designed to address conditions such as depression, migraines, and other neurological and psychiatric disorders. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.
Key slides for Axsome Therapeutics Inc


Q4 2024
Axsome Therapeutics Inc


Study Result
Axsome Therapeutics Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
AXSM
Country
🇺🇸 United States